Cargando…

Sodium-glucose cotransporter-2 inhibitor use in kidney transplant recipients

Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are novel oral hypoglycemic agents garnering much attention for their substantial benefits. These recent data have positioned SGLT2i at the forefront of diabetic chronic kidney disease (CKD) and heart failure management. SGLT2i use post-kidney trans...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramakrishnan, Pavithra, Garg, Neetika, Pabich, Samantha, Mandelbrot, Didier A, Swanson, Kurtis J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514750/ https://www.ncbi.nlm.nih.gov/pubmed/37746038 http://dx.doi.org/10.5500/wjt.v13.i5.239

Ejemplares similares

Chances and risks of sodium-glucose cotransporter 2 inhibitors in solid organ transplantation: A review of literatures
por: Schwarzenbach, Marlene, et al.
Publicado: (2021)

Sodium glucose cotransporter 2 inhibitors: New horizon of the heart failure pharmacotherapy
por: Naito, Ryo, et al.
Publicado: (2021)

Role of novel biomarkers in kidney transplantation
por: Swanson, Kurtis J, et al.
Publicado: (2020)

Kidney disease in non-kidney solid organ transplantation
por: Swanson, Kurtis J
Publicado: (2022)

Searching in the maze: sodium–glucose cotransporter-2 inhibitors in kidney transplant recipients to improve survival
por: Oliveras, Laia, et al.
Publicado: (2023)

Sodium-glucose cotransporter-2 inhibitors (SGLT2i) in kidney transplant recipients: what is the evidence?
por: Ujjawal, Aditi, et al.
Publicado: (2022)

Prescribing Patterns for Sodium-Glucose Cotransporter 2 Inhibitors: A Survey of Nephrologists
por: Singh, Tripti, et al.
Publicado: (2023)

The care of kidney transplant recipients during a global pandemic: Challenges and strategies for success
por: Aziz, Fahad, et al.
Publicado: (2020)

Post-transplant erythrocytosis after kidney transplantation: A review
por: Alzoubi, Beyann, et al.
Publicado: (2021)

Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes
por: Garg, Neetika, et al.
Publicado: (2018)

Delayed Graft Function Among Kidney Transplant Recipients Is Associated With an Increased Risk of Urinary Tract Infection and BK Viremia
por: Alshaikh, Eman A., et al.
Publicado: (2023)

Early Report on Published Outcomes in Kidney Transplant Recipients Compared to Nontransplant Patients Infected With Coronavirus Disease 2019
por: Aziz, Fahad, et al.
Publicado: (2020)

The Trend of Serum Creatinine Does Not Predict Follow-Up Biopsy Findings Among Kidney Transplant Recipients With Antibody-Mediated Rejection
por: Parajuli, Sandesh, et al.
Publicado: (2023)

Continuation of Peritoneal Dialysis in Adult Kidney Transplant Recipients With Delayed Graft Function
por: Gardezi, Ali I., et al.
Publicado: (2021)

Significance of Asymptomatic Pyelonephritis Found on Kidney Transplant Biopsy
por: Aziz, Fahad, et al.
Publicado: (2021)

Pancreas Retransplant After Pancreas Graft Failure in Simultaneous Pancreas-kidney Transplants Is Associated With Better Kidney Graft Survival
por: Parajuli, Sandesh, et al.
Publicado: (2019)

Introduction of everolimus in kidney transplant recipients at a late posttransplant stage
por: Uchida, Junji, et al.
Publicado: (2018)

Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients: Treatment Response Rates and Value of Early Surveillance Biopsies
por: Aziz, Fahad, et al.
Publicado: (2022)

Mycophenolate Monotherapy in HLA-Matched Kidney Transplant Recipients: A Case Series of 20 Patients
por: Hennes, Anthony J., et al.
Publicado: (2020)

More than skin deep? Potential nicotinamide treatment applications in chronic kidney transplant recipients
por: Bostom, Andrew G, et al.
Publicado: (2016)

Does steroid-free immunosuppression improve the outcome in kidney transplant recipients compared to conventional protocols?
por: Aref, Ahmed, et al.
Publicado: (2021)

Sodium‐glucose cotransporter 2 inhibitors in heart failure with chronic kidney disease
por: Kato, Shingo, et al.
Publicado: (2022)

How Should Acute T-cell Mediated Rejection of Kidney Transplants Be Treated: Importance of Follow-up Biopsy
por: Aziz, Fahad, et al.
Publicado: (2022)

Cardiovascular effects of sodium glucose cotransporter 2 inhibitors
por: Cavaiola, Tricia Santos, et al.
Publicado: (2018)

Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors
por: Sano, Motoaki
Publicado: (2017)

Sodium-glucose cotransporter inhibitors: beyond glycaemic control
por: Vergara, Ander, et al.
Publicado: (2019)

Renal outcomes with sodium-glucose cotransporters 2 inhibitors
por: Sun, Xiaoya, et al.
Publicado: (2022)

Renal transplant recipient seizure practical management
por: Sawhney, Harpreet, et al.
Publicado: (2020)

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Water and Sodium Metabolism
por: Tang, Jun, et al.
Publicado: (2022)

The Application of Sodium-Glucose Cotransporter 2 Inhibitors to Chronic Kidney Disease Stage 4
por: Koguchi, Ayako, et al.
Publicado: (2017)

Sodium-glucose cotransporter 2 inhibitors for diabetic kidney disease: a primer for deprescribing
por: Li, Jiahua, et al.
Publicado: (2019)

Editorial: The role of sodium-glucose cotransporter 2 inhibitors in the management of chronic kidney disease
por: Heerspink, Hiddo J L, et al.
Publicado: (2020)

Sodium-glucose cotransporter 2 inhibitor effects on cardiovascular outcomes in chronic kidney disease
por: Shivakumar, Oshini, et al.
Publicado: (2020)

Sodium-glucose cotransporter 2 inhibitors: extending the indication to non-diabetic kidney disease?
por: Dekkers, Claire C J, et al.
Publicado: (2020)

Metabolomic profiling in kidney cells treated with a sodium glucose-cotransporter 2 inhibitor
por: Jo, Hyung Ah, et al.
Publicado: (2023)

Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti‐IL2 Receptor Monoclonal Antibodies?
por: Hellemans, R., et al.
Publicado: (2016)

Sodium-glucose cotransporter-2 inhibitor therapy in kidney transplant patients with type 2 or post-transplant diabetes: an observational multicentre study
por: Sánchez Fructuoso, Ana I, et al.
Publicado: (2023)

Addictive behaviors in liver transplant recipients: The real problem?
por: Donnadieu-Rigole, Hélène, et al.
Publicado: (2017)

Impact of low‐level pretransplant donor‐specific antibodies on outcomes after kidney transplantation
por: Parajuli, Sandesh, et al.
Publicado: (2021)

Treatment of Chronic Active Antibody-mediated Rejection With Pulse Steroids, IVIG, With or Without Rituximab is Associated With Increased Risk of Pneumonia
por: Joachim, Emily, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_02ns7pbedoaf5o7khf6726npbe